These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 5554418)

  • 1. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor.
    Okubo S
    Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune reactions in Ehrlich ascites tumour-bearing mice.
    Olinescu A; Babeş S; Piţur I
    Arch Roum Pathol Exp Microbiol; 1980; 39(3):249-57. PubMed ID: 7018456
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on anti-tumor immunity. II. Studies on inhibitory effect of heterologous spleen cells on the growth of Ehrlich ascites tumor.
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Mar; 26(12):1609-16. PubMed ID: 5232510
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunity against the Ehrlich ascites carcinoma produced by bacterial endotoxins.
    Hager EB; Bailey GL; Hampers CL; Merrill JP
    Transplant Proc; 1969 Mar; 1(1):124-5. PubMed ID: 4944208
    [No Abstract]   [Full Text] [Related]  

  • 6. [Data concerning protective substances in immune tissues (short report)].
    Glezer IM; Geĭtman IIa
    Biull Eksp Biol Med; 1968; 66(7):92-3. PubMed ID: 5758105
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
    Culo F; Marić M; Morović-Vergles J
    In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Ehrlich ascites carcinoma on repopulating ability of mouse bone marrow cells.
    Clerici E; Mocarelli P; Villa ML; Natale N
    J Natl Cancer Inst; 1971 Sep; 47(3):555-60. PubMed ID: 4945589
    [No Abstract]   [Full Text] [Related]  

  • 9. Blastogenic response of lymphoid cells to tumor cells or tumor membrane extracts in vitro.
    Poon SP; Cauchi MN
    Cancer Res; 1973 Nov; 33(11):2677-82. PubMed ID: 4270637
    [No Abstract]   [Full Text] [Related]  

  • 10. Augmentation of antitumour activity of xenogeneic antiserum by normal xenogeneic spleen cells in mice.
    Dobaczewska H; Lasek W; Marczak M; Obłakowski P; Jakóbisiak M
    Folia Biol (Krakow); 1981; 29(1):77-81. PubMed ID: 7238955
    [No Abstract]   [Full Text] [Related]  

  • 11. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.
    Baral R; Chattopadhyay U
    Int Immunopharmacol; 2004 Mar; 4(3):355-66. PubMed ID: 15037213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice.
    Sheeja K; Kuttan G
    Integr Cancer Ther; 2007 Mar; 6(1):66-73. PubMed ID: 17351028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells.
    Häkkinen I; Halonen P
    J Natl Cancer Inst; 1971 Jun; 46(6):1161-7. PubMed ID: 4325929
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
    Saha S; Mondal S
    Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on anti-tumor immunity. I. Homologous immunity against Ehrlich ascites tumor (acquired type of immunity against tumor).
    Soeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Mar; 26(12):1598-608. PubMed ID: 5232509
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression induced with cell-free fluid of Ehrlich carcinoma ascites and its fractions.
    Yamazaki H; Nitta K; Umezawa H
    Gan; 1973 Feb; 64(1):83-92. PubMed ID: 4577968
    [No Abstract]   [Full Text] [Related]  

  • 17. Restoration of allograft immunity in tumor-bearing animals by "immune" RNA.
    Rigby PG
    J Lab Clin Med; 1968 May; 71(5):775-83. PubMed ID: 4869636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunity and tumors].
    Michelazzi L
    Boll Ist Sieroter Milan; 1971; 50(3):185-91. PubMed ID: 4337946
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radiotherapy and immune reactions of spleen cells in experimental tumors].
    Juliani G; Cirillo R; Ballaira L; Fava C
    Minerva Radiol; 1969 Nov; 14(11):494-8. PubMed ID: 5383669
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resistance to Ehrlich's ascites carcinoma in mice immunized with killed tumor cells].
    D'Alessandro G; Giammanco G; Barncato P
    Riv Ist Sieroter Ital; 1967; 42(6):332-49. PubMed ID: 5601777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.